FDA Approved: DECITABINE — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for decitabine by BluePoint Laboratories, authorizing a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Decitabine (Decitabine)

Snippet

SUPPL AP for DECITABINE (DECITABINE)